News

Growth in Mainframe Investment Amid Rise of Cloud Computing

Growth in Mainframe Investment Amid Rise of Cloud Computing

Increasing Mainframe Investment Amid Cloud Growth

Recent research has revealed a surprising trend among companies that utilize mainframes as part of their IT infrastructure. These organizations are planning to boost their spending on mainframes, even while they continue to embrace public cloud solutions. A comprehensive study conducted by Information Services Group (ISG) sheds light on this evolving landscape.

Mixed Priorities for Enterprises

The ISG Market Lens™ Mainframe and Mainframe as a Service (MFaaS) Study found that a significant proportion of large enterprises are expecting changes in their mainframe operations. Around one-third of those surveyed plan to upgrade their existing mainframe processors or storage capabilities. Moreover, 40% of respondents are looking to increase their capacity for traditional mainframe systems, while approximately one in six are considering the purchase of a new mainframe within the next few years.

Strategic Balancing Act

As Alex Bakker, a distinguished analyst at ISG, points out, mainframes continue to hold a crucial position in large enterprises. Companies find themselves navigating a challenging balancing act between maintaining their mainframe systems, adopting MFaaS options, and leveraging public cloud services. Despite the rapid growth of public cloud adoption, Bakker emphasizes that it is unlikely to fully replace the need for mainframes in enterprise settings.

Persistent Demand for Mainframe Resources

The ISG study, which surveyed 200 top executives responsible for mainframe strategies across the Americas and Europe, indicates that enterprises with the heaviest IT workloads are projected to face the greatest increases in demand across all platforms. Interestingly, firms characterized by a high reliance on traditional mainframe systems are more likely to shift towards MFaaS solutions to meet their evolving operational needs.

Navigating Legacy Challenges

Another intriguing insight from the research highlights why demand for mainframe capabilities remains robust. Enterprises are often hindered by the challenges inherent in decommissioning outdated legacy systems. As the landscape evolves, conflicting priorities such as the emergence of AI, data security, and the need for system resilience become evident. According to Michael Dornan, a principal analyst at ISG, this dynamic pressure underscores the importance of modernizing these outdated systems while managing cost optimization concerns.

Cloud Migration and Cost Concerns

In recent years, many firms have made notable strides in cloud migration. Approximately 60% of those surveyed have moved some applications to the cloud, and over 40% have migrated to MFaaS solutions. This trend highlights the appeal of MFaaS as a cost-effective option that combines the agility of public cloud infrastructure with fewer risks related to migration and security issues. Additionally, the rising need for mainframe skills poses a challenge, as industry veterans retire and younger professionals often lack proficiency in legacy programming languages.

Pressures on IT Departments

As organizations endeavor to enhance their technological capabilities, priorities are shifting towards key areas such as cost optimization, retiring legacy systems, integrating AI capabilities, and enhancing cybersecurity measures. However, only information security appears to be performing satisfactorily, with 54% of respondents affirming that their security measures outshine those of their peers. Comparatively, cost reduction efforts, AI integration, and legacy system retirement are perceived as lagging in effectiveness.

The Future of Mainframe Modernization

The outlook for mainframe investment suggests a robust future, driven by a combination of rising application storage demands and the constant pressure on IT departments to reduce costs. Nearly all participants indicated that they are engaging managed service providers to facilitate the modernization and ongoing management of their mainframe systems or MFaaS services.

Conclusion: A Call for Modernization Support

As companies contend with the challenges linked to mainframe investments, there is a growing expectation for service providers to deliver not only cost optimization solutions but also to maximize the benefits derived from legacy system integration with modern operations, including cloud technology. The role of external expertise will likely become increasingly critical in helping organizations unlock the full potential of their mainframe investments.

Frequently Asked Questions

What is the main finding of the ISG study?

The study indicates that companies using mainframes plan to increase their mainframe spending even as they adopt more public cloud solutions.

Why are enterprises increasing spending on mainframes?

Many organizations are unable to decommission legacy systems due to conflicting priorities like AI adoption and security needs, driving the demand for mainframe resources.

What challenges do companies face with mainframe modernization?

Accessing skilled talent is increasingly difficult as industry veterans retire and new employees often lack knowledge of legacy programming languages.

What areas are enterprises focusing on for improvement?

Enterprises are prioritizing cost optimization, legacy system retirement, AI capabilities, and information security, although security appears to be performing best.

How do managed service providers fit into mainframe strategy?

Nearly all respondents are utilizing managed service providers to aid with mainframe modernization and operations, highlighting the need for external support in this area.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 19

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 14

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 11

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 10

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 20

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 17

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 8

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading

Top 5 Most Recently Viewed Articles

Sera Prognostics to Showcase Innovations at RBC Healthcare Event

Updated Category News Views 112

Sera Prognostics to Showcase Innovations at RBC Healthcare Event Sera Prognostics Inc., known as The Pregnancy Company (NASDAQ: SERA), is focused on enhancing maternal and neonatal health through innovative pregnancy biomarker information. The company has recently announced its participation at an important healthcare event, highlighting its ongoing commitment to improve...

Continue Reading
Unlocking AI Potential: Insights from Netcracker CEO Andrew Feinberg

Updated Category News Views 268

Exciting Keynote at GITEX Global 2024 Netcracker Technology is buzzing with excitement as Andrew Feinberg, the Chairman and CEO, prepares for a pivotal keynote presentation at one of the largest tech events in the world, GITEX Global 2024. This annual technology conference draws innovators, industry leaders, and enthusiasts keen on understanding the future of technology....

Continue Reading
Adherium Empowers COPD and Asthma Management with iCARE Study

Updated Category News Views 147

Adherium's Transformative iCARE Study Results The innovative strides made by Adherium Limited (ASX:ADR) in respiratory health have shown promising outcomes as seen in the iCARE study. This study investigated the effectiveness of their Hailie® Smartinhaler® technology in improving adherence among patients suffering from chronic obstructive pulmonary disease (COPD) and...

Continue Reading
Medius Highlights Impending Finance Challenges Post AI Launch

Updated Category News Views 243

AI Fraud Concerns Elevate in the Finance Sector Medius has unveiled alarming findings indicating that nearly one in three finance professionals are unable to spot AI-generated fake receipts. This revelation surfaces amidst rising fears of fraud escalation following the recent launch of GPT-5.0. With the capabilities of AI continuously improving, finance teams must prepare...

Continue Reading
TD Cowen Sustainably Endorses Abbott Labs with Robust Price Target

Updated Category News Views 59

TD Cowen Affirms Buy Rating on Abbott Laboratories TD Cowen has reaffirmed its Buy rating on Abbott Laboratories (NYSE: ABT), maintaining a price target of $130.00 for the healthcare company's shares. This positive stance hinges on expectations that Abbott's upcoming third-quarter results will either meet or surpass current market predictions, allowing the company to...

Continue Reading